ELS vs GSK · P/E 32, rev $1.53B vs P/E 13, $103.31B cap
Equity Lifestyle Properties Inc (ELS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Equity Lifestyle Properties Inc (ELS) is a reit - residential company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ELS revenue for 2025-12-31 was $1.53B. Net income was $402.1M. Revenue was up 0.3% from 2024-12-31 to 2025-12-31. ELS currently screens at market cap $12.37B and trailing P/E 31.8.
GSK does not have a complete income-statement cache yet.
ELS currently screens at market cap $12.37B and trailing P/E 31.8. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ELS and GSK stock pages for the full models.
Not investment advice.